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tion Modeling (SEM) techniques to evaluate the SF-36
and the impact of NA on the Mental and Physical Com-
ponents in a sample taken from the 1990 National Sur-
vey of Functional Health Status (NHS). RESULTS: The
percent of shared variance of the Physical Health and
Mental Health indicators and the Physical and Mental
Health factors combined are physical function (.0603),
role physical (.0817), bodily pain (.0720), health percep-
tion (.0600), role emotional (.0486), vitality (.0756), gen-
eral mental health (.5207) and social function (.0811).
General mental health (GMH) indicators are virtually
identical to NA indicators. The percent of shared vari-
ance of the NA/GMH factor and Physical Health and
Mental Health is .4422 and .9781 respectively. CON-
CLUSIONS: The present results suggest that about 47
percent of Physical Health and 98 percent of Mental
Health is due to the influence of NA/GMH. This may ac-
count for the lack of discriminative ability, shown in pre-
vious studies, of the Mental Health factor and Mental
Component Scale Score.
PQP11
THE HEALTH AND WORK QUESTIONNAIRE 
(HWQ): AN INSTRUMENT FOR ASSESSING 
WORKPLACE PRODUCTIVITY IN RELATION TO 
WORKER HEALTH
Shikiar R1, Rentz AM2, Halpern MT3, Khan ZM4
1MEDTAP International, Seattle, WA, USA; 2MEDTAP 
Intertnational Inc, Bethesda, MD, USA; 3Charles River 
Associates, Washington, DC, USA; 4GlaxoSmithKline,
Research Triangle Park, NC, USA
OBJECTIVE: Recently, interest has increased in produc-
tivity loss associated with medical conditions or health
behaviors that do not preclude attendance at work (e.g.,
migraine, smoking). Commonly, productivity loss is sub-
jectively assessed (asking workers directly to report on
the productivity impacts of their medical conditions or
health behaviors) which may be problematic because cer-
tain illnesses or health behaviors are viewed as socially
undesirable. We describe the initial validation of a new
instrument, the Health and Work Questionnaire (HWQ)
that can be used in studies of worker health and produc-
tivity. METHOD: The HWQ consists of 24 items assess-
ing work quality, quantity, efficiency, and related factors.
To minimize “social desirability” tendencies on the part
of respondents, they are asked to rate their work quality,
quantity, and efficiency from their supervisor’s and their
co-worker’s perspectives as well as their own. All items
have ten-point response scales. The initial questionnaire
was pretested by 30 subjects. Based on subject feedback,
no wording changes were deemed necessary. The HWQ
was administered to 294 employees of a major US airline
and was completed at baseline and at three subsequent
monthly intervals. Validation included comparisons with
two objective productivity measures collected by the air-
line: Time Lost, the average time a reservation agent is
unavailable between calls; and Total Performance Points,
the performance measure used for quarterly employee
evaluation. RESULTS: Six subscales were identified by
factor analyses: productivity, concentration/focus, supervi-
sor relations, impatience/irritability, work satisfaction, and
non-work satisfaction. Internal consistency reliability val-
ues were high for all scales (0.84–0.96), with the exception
of impatience/irritability, displaying adequate reliability
(0.72). All HWQ scale scores correlated significantly with
the Time Lost measure; two scales correlated significantly
with the performance measure. The significant correlations
were all modest (0.12 to 0.22). CONCLUSIONS: With
other measures, the HWQ may be a useful instrument in
assessing group differences and evaluating the impact of
health interventions on work-place productivity.
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Pharmaceutical science has moved away from focusing
exclusively on the impact of medications on physiological
parameters to a focus that includes the subject’s quality
of life (QoL). To date, QoL assessment has relied exclu-
sively on global summaries that ask subjects to recall,
summarize, and evaluate their subjective QoL. New sci-
ence-based methods using handheld technology to gather
QoL data can lead to more valid, reliable, and timely
QoL data. Many of the components of QoL, from subjec-
tive well-being to objective functioning, derive from an
interest in understanding a subject’s daily and momen-
tary experiences. Rather than relying on broad summa-
ries of experience, a ‘bottoms-up’ approach to QoL as-
sessment directly measures subjects’ momentary QoL in
real-time, in the real-world. Until recently, researchers
did not have an efficient way to collect valid momentary
QoL data from subjects in their natural environment. Re-
cent methodological advances in the science of patient
experience, termed Ecological Momentary Assessment
(EMA), make it possible to collect real-time QoL data
from subjects using electronic patient experience diaries.
This ‘bottoms-up’ approach using EMA methods extends
existing QoL measures by providing a unique perspective
on the extent to which subjects’ evaluations of various
moments in their lives reflect QoL changes over time. Re-
cent empirical evidence suggests that this ‘bottoms-up’
approach may enhance the sensitivity of QoL assessment
in clinical trials. The new perspective EMA provides on
momentary patient experience represents a promising
methodological advancement in the study of QoL. In
combination with standard written assessments of QoL,
EMA data can provide a new perspective on the relation-
ship between medication effects and QoL.
